A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2− advanced breast cancer

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2− advanced breast cancer
Authors
Keywords
Endocrine therapy, Everolimus, Hormone receptor-positive advanced breast cancer, mTOR inhibitor, Overall survival, Progression-free survival
Journal
CANCER TREATMENT REVIEWS
Volume 41, Issue 2, Pages 94-104
Publisher
Elsevier BV
Online
2014-12-30
DOI
10.1016/j.ctrv.2014.12.011

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.